Analyst Price Targets — ACA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 3, 2025 11:32 am | Adam Seiden | Barclays | $115.00 | $102.00 | TheFly | Arcosa price target raised to $115 from $106 at Barclays |
| October 29, 2024 5:49 am | Adam Seiden | Barclays | $106.00 | $95.42 | TheFly | Arcosa initiated with an Overweight at Barclays |
| August 7, 2024 6:16 am | Trey Grooms | Stephens | $96.00 | $77.70 | TheFly | Arcosa upgraded to Overweight at Stephens on benefits of portfolio actions |
| August 5, 2024 9:12 am | Garik Shmois | Loop Capital Markets | $110.00 | $79.12 | TheFly | Arcosa price target raised to $110 from $95 at Loop Capital |
| May 17, 2024 8:29 am | Brent Thielman | D.A. Davidson | $110.00 | $86.82 | TheFly | Arcosa price target raised to $110 from $105 at DA Davidson |
| May 6, 2024 9:13 am | Brent Thielman | D.A. Davidson | $105.00 | $86.34 | StreetInsider | Arcosa (ACA) PT Raised to $105 at DA Davidson |
| August 8, 2022 9:20 am | — | Stephens | $70.00 | $62.79 | Benzinga | Stephens & Co. Maintains Overweight on Arcosa, Raises Price Target to $70 |
Latest News for ACA
Arcosa, Inc. (NYSE: ACA - Get Free Report)'s share price gapped down prior to trading on Friday. The stock had previously closed at $127.50, but opened at $118.90. Arcosa shares last traded at $111.89, with a volume of 155,316 shares traded. Key Stories Impacting Arcosa Here are the key news stories impacting Arcosa this week:
Arcosa, Inc. (ACA) Q4 2025 Earnings Call Transcript
While the top- and bottom-line numbers for Arcosa (ACA) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Arcosa (ACA) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $0.46 per share a year ago.
DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa,” the “Company,” “We,” or “Our”), a provider of infrastructure-related products and solutions, today announced results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Highlights Three Months Ended December 31, 2025 2024 % Change ($ in millions, except per share amounts) Revenues $ 716.7…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
No House trades found for ACA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.